Toxicity for warfarine switching from lopinavir/ritonavir to dolutegravir
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria - 41(2017), 2 vom: 01. März, Seite 315-316 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Toxicidad por warfarina al cambiar lopinavir/ ritonavir por dolutegravir: a propósito de un caso |
|---|
| Beteiligte Personen: |
Pelufo-Pellicer, Ana [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 25.06.2018 Date Revised 09.12.2020 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.7399/fh.2017.41.2.10685 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM269287795 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM269287795 | ||
| 003 | DE-627 | ||
| 005 | 20231224224251.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.7399/fh.2017.41.2.10685 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0897.xml |
| 035 | |a (DE-627)NLM269287795 | ||
| 035 | |a (NLM)28236805 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Pelufo-Pellicer, Ana |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Toxicity for warfarine switching from lopinavir/ritonavir to dolutegravir |
| 246 | 3 | 3 | |a Toxicidad por warfarina al cambiar lopinavir/ ritonavir por dolutegravir: a propósito de un caso |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.06.2018 | ||
| 500 | |a Date Revised 09.12.2020 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Anti-HIV Agents |2 NLM | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 650 | 7 | |a HIV Protease Inhibitors |2 NLM | |
| 650 | 7 | |a Heterocyclic Compounds, 3-Ring |2 NLM | |
| 650 | 7 | |a Oxazines |2 NLM | |
| 650 | 7 | |a Piperazines |2 NLM | |
| 650 | 7 | |a Pyridones |2 NLM | |
| 650 | 7 | |a Lopinavir |2 NLM | |
| 650 | 7 | |a 2494G1JF75 |2 NLM | |
| 650 | 7 | |a Warfarin |2 NLM | |
| 650 | 7 | |a 5Q7ZVV76EI |2 NLM | |
| 650 | 7 | |a dolutegravir |2 NLM | |
| 650 | 7 | |a DKO1W9H7M1 |2 NLM | |
| 650 | 7 | |a Ritonavir |2 NLM | |
| 650 | 7 | |a O3J8G9O825 |2 NLM | |
| 700 | 1 | |a López-Montenegro Soria, MªÁngeles |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria |d 1998 |g 41(2017), 2 vom: 01. März, Seite 315-316 |w (DE-627)NLM093839022 |x 2171-8695 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2017 |g number:2 |g day:01 |g month:03 |g pages:315-316 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.7399/fh.2017.41.2.10685 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2017 |e 2 |b 01 |c 03 |h 315-316 | ||